Submission delayed by U.S. government shutdown; initial FDA questions expected during Q4 2025 "The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch ...

Pandemic-era subsidies that made Affordable Care Act plans cheaper are set to expire at the end of 2025. Millions of Americans will face significantly higher health insurance costs or lose coverage ...

It can be difficult to wear an insulin pump or other diabetes device on your body. Use these tips to help manage your use of this technology and avoid any hiccups that might arise. Share on Pinterest ...

You don’t have to choose between managing your diabetes and enjoying your hygiene routine. You can take steps to keep your devices safe while showering or bathing, whether you prefer to disconnect ...

[Image from Medtronic] A Minnesota judge has dismissed a class action lawsuit alleging securities fraud related to insulin pumps made by Medtronic (NYSE:MDT). Laura M. Provinzino, U.S. District Judge ...

Medtronic PLC investors again failed to adequately allege the device maker’s statements about its MiniMed insulin pumps constituted securities fraud, a federal court said. The latest version of the ...

George Kelesidis, of Greece, who uses the MiniMed 780G system to manage his diabetes. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) today shared real-world evidence highlighting improvements with ...

The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...

FRANKLIN LAKES, N.J. (Sept. 12, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today expanded their Class I voluntary recall initiated in the ...

Medtronic has obtained a pair of major green lights from the FDA for its flagship insulin pump—opening up the MiniMed 780G to adults with Type 2 diabetes in the U.S. and allowing it to connect with a ...